Pathophysiology of Peyronie's disease (Q35010236)

5 August 2017

1 reference

title

Pathophysiology of Peyronie's disease (English)

1 reference

5 August 2017

1 reference

Moreland RB

1

1 reference

5 August 2017

Nehra A

series ordinal

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

International Journal of Impotence Research

5 August 2017

published in

1 reference

5 August 2017

volume

14

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

406-410

1 reference

Peyronie's disease is associated with Paget's disease of bone

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Anatomy and strength of the tunica albuginea: its relevance to penile prosthesis extrusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

The Anatomy of the Tunica Albuginea in the Normal Penis and Peyronie's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Engineering analysis of penile hemodynamic and structural-dynamic relationships: Part I--Clinical implications of penile tissue mechanical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Transforming growth factor-beta in disease: the dark side of tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Is there a role of hypoxemia in penile fibrosis: a viewpoint presented to the Society for the Study of Impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Oxidative damage and fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Is colchicine effective in Peyronie's disease? A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

The treatment of Peyronie's disease with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

Penile trauma: an etiologic factor in Peyronie's disease and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Mechanisms of calcification in Peyronie's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Penile vascular evaluation of men with Peyronie's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Immunologic findings in Peyronie's disease: a controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Histological and ultrastructural alterations in an animal model of Peyronie's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Treatment of Peyronie's disease with potassium para-aminobenzoate (potaba)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Intralesional interferon in the treatment of Peyronie's disease: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900875

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3900875

1 reference

5 August 2017

1 reference